StonvexLoading…
StonvexStonvexStonvexCore line items from MATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.34B | $3.42B | $3.09B | $4.34B |
Operating Income | $499.80M | $551.30M | $342.80M | $1.35B |
Net Income | $444.80M | $476.40M | $297.10M | $1.06B |
EPS (Diluted) | $13.81 | $13.93 | $8.32 | $27.07 |
Total Assets | $4.64B | $4.60B | $4.29B | $4.33B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $141.90M | $266.80M | $134.00M | $249.80M |
Free Cash Flow OCF − CapEx | $153.70M | $457.70M | $262.10M | $1.06B |
Shares Outstanding | 30.40M | 33.00M | 34.40M | 36.30M |